| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―21 |
Neurologic Manifestations of Long
COVID
Affect Adult Females More Severely Than Males |
Hannah Kopinsky, Melissa Lopez, Janet Miller, Millenia Jimenez, Eric M. Liotta, Igor J. Koralnik |
| 2 |
[GO] |
2025―Sep―05 |
Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross-Sectional Study |
Chen Hu, Jiyeon Son, Lindsay McAlpine, Elizabeth L. S. Walker, Megan Dahl, Emily Song, Sugeidy Ferreira Brito, Katelyn Kavak, Kaho Onomichi, Amit Bar-Or, Christopher Perrone, Claire S. Riley, Bianca Weinstock-Guttman, Philip L. De Jager, Erin E. Longbrake, Zongqi Xia |
| 3 |
[GO] |
2025―May―19 |
Corrigendum to “Clinical Phenotyping of Long COVID Patients Evaluated in a Specialized Neuro-COVID Clinic” |
|
| 4 |
[GO] |
2025―Apr―09 |
Clinical Phenotyping of Long COVID Patients Evaluated in a Specialized Neuro-COVID Clinic |
Luana D. Yamashita, Neel Desai, Abigail R. Manning, Caitlin Pileggi, Sara Manning Peskin, Danielle K. Sandsmark, Dennis L. Kolson, Matthew K. Schindler |
| 5 |
[GO] |
2024―Jul―31 |
MRI evidence of gray matter loss in COVID-19 patients with cognitive and olfactory disorders |
Serena Capelli, Alberto Arrigoni, Angela Napolitano, Giulio Pezzetti, Andrea Remuzzi, Rosalia Zangari, Ferdinando Luca Lorini, Maria Sessa, Anna Caroli, Simonetta Gerevini |
| 6 |
[GO] |
2024―Jul―19 |
Objective and subjective cognitive outcomes one year after COVID-19 |
Laura Zamarian, Verena Rass, Elisabeth Goettfried, Valentina Mayr, Federico Carbone, Philipp Kindl, Margarete Delazer, Atbin Djamshidian, Alessandra Fanciulli, Philipp Mahlknecht, Beatrice Heim, Marina Peball, Alois Josef Schiefecker, Klaus Seppi, Judith Löffler-Ragg, Ronny Beer, Bettina Pfausler, Stefan Kiechl, Raimund Helbok |
| 7 |
[GO] |
2024―Jul―04 |
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population |
Lisa Shigematsu, Ryusei Kimura, Hideki Terai, Yu Mimura, Daisuke Ito, Shogyoku Bun, Ho Namkoong, Takanori Asakura, Shotaro Chubachi, Katsunori Masaki, Keiko Ohgino, Jun Miyata, Ichiro Kawada, Makoto Ishii, Ryo Takemura, Soichiro Ueda, Takashi Yoshiyama, Hiroyuki Kokuto, Tatsuya Kusumoto, Ayano Oashi, Masayoshi Miyawaki, Fumitake Saito, Tetsuo Tani, Kota Ishioka, Saeko Takahashi, Morio Nakamura, Yasunori Sato, Koichi Fukunaga |
| 8 |
[GO] |
2024―May―07 |
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination |
Ilya Kister, Ryan Curtin, Amanda L. Piquet, Tyler Borko, Jinglan Pei, Barbara L Banbury, Tamar E. Bacon, Angie Kim, Michael Tuen, Yogambigai Velmurugu, Samantha Nyovanie, Sean Selva, Marie I. Samanovic, Mark J. Mulligan, Yury Patskovsky, Jessica Priest, Mark Cabatingan, Ryan C. Winger, Michelle Krogsgaard, Gregg J. Silverman |
| 9 |
[GO] |
2023―Dec―22 |
Cognitive and emotional predictors of quality of life and functioning after COVID-19 |
Mar Ariza, Neus Cano, Bàrbara Segura, Javier Bejar, Cristian Barrué, Claudio Ulises Cortés, Carme Junqué, Maite Garolera |
| 10 |
[GO] |
2023―Oct―09 |
High-resolution MR neurography follow-up of SARS-CoV-2 vaccination-associated neuralgic amyotrophy |
Christoph M. Mooshage, Henrich Kele, Martin Bendszus, Daniel Schwarz |
| 11 |
[GO] |
2023―Aug―08 |
SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis |
Bruce A. C. Cree, Rachel Maddux, Amit Bar-Or, Hans-Peter Hartung, Amandeep Kaur, Elizabeth Brown, Yicong Li, Yanhua Hu, James K. Sheffield, Diego Silva, Sarah Harris |
| 12 |
[GO] |
2023―Jun―25 |
Neurological diagnoses in hospitalized COVID-19 patients during the B.1.1.529 surge |
Carla Y. Kim, Zomer Sardar, Biniyam A. Ayele, Shannon Fleck-Derderian, Catherine E. Barrett, Yifei Sun, Madison Clague, Holly A. Hurst, Abhilasha Boruah, Jason Zucker, Ryan Maddox, James Sejvar, Kiran T. Thakur |
| 13 |
[GO] |
2023―Jun―15 |
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC |
Lucette A. Cysique, David Jakabek, Sophia G. Bracken, Yasmin Allen-Davidian, Benjamin Heng, Sharron Chow, Mona Dehhaghi, Ananda Staats Pires, David R. Darley, Anthony Byrne, Chansavath Phetsouphanh, Anthony Kelleher, Gregory J. Dore, Gail V. Matthews, Gilles J. Guillemin, Bruce J. Brew |
| 14 |
[GO] |
2023―Jun―02 |
Exploring risk factors for persistent neurocognitive sequelae after hospitalization for COVID-19 |
Peter Y. Ch'en, Laura S. Gold, Qiongshi Lu, Ting Ye, James S. Andrews, Payal Patel |
| 15 |
[GO] |
2023―May―04 |
Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against
SARS-CoV
-2 |
Salvatore Iacono, Tommaso Piccoli, Paolo Aridon, Giuseppe Schirò, Valeria Blandino, Domenico Tarantino, Luisa Agnello, Marcello Ciaccio, Paolo Ragonese, Giuseppe Salemi |
| 16 |
[GO] |
2022―Dec―16 |
Structural brain changes in post-acute COVID-19 patients with persistent olfactory dysfunction |
Anna Campabadal, Javier Oltra, Carme Junqué, Núria Guillen, María Ángeles Botí, Roser Sala-Llonch, Gemma C. Monté-Rubio, Gema Lledó, Nuria Bargalló, Lorena Rami, Raquel Sánchez-Valle, Bàrbara Segura |
| 17 |
[GO] |
2022―Sep―06 |
Impact of
COVID
-19 pandemic on patients with Parkinson's disease: A meta-analysis of 13,878 patients |
Aaron Shengting Mai, Jung Hahn Yong, Brendan Jen-Wei Tan, Bin Xiao, Eng-King Tan |
| 18 |
[GO] |
2022―Sep―02 |
Postvaccinal GABA-B receptor antibody encephalitis after ChAdOx1 nCoV-19 vaccination |
Seon-Jae Ahn, Soon-Tae Lee, Kon Chu |
| 19 |
[GO] |
2022―Jul―19 |
Immune responses to
SARS-CoV
-2 vaccination in multiple sclerosis: a systematic review/meta-analysis |
Grace Y. Gombolay, Monideep Dutt, William Tyor |
| 20 |
[GO] |
2022―Jun―17 |
SARS-COV
-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder |
Magnus Johnsson, Fredrik Asztely, Susanne Hejnebo, Markus Axelsson, Clas Malmeström, Torbjörn Olausson, Jan Lycke |
| 21 |
[GO] |
2022―Jun―15 |
Longitudinal evaluation of
neurologic-post
acute sequelae
SARS-CoV
-2 infection symptoms |
Jacqueline E. Shanley, Andrew F. Valenciano, Garrett Timmons, Annalise E. Miner, Visesha Kakarla, Torge Rempe, Jennifer H. Yang, Amanda Gooding, Marc A. Norman, Sarah J. Banks, Michelle L. Ritter, Ronald J. Ellis, Lucy Horton, Jennifer S. Graves |
| 22 |
[GO] |
2022―Jan―21 |
Long COVID-19: Objectifying most self-reported neurological symptoms |
Julia Bungenberg, Karen Humkamp, Christian Hohenfeld, Marcus Immanuel Rust, Ummehan Ermis, Michael Dreher, Niels-Ulrik Korbinian Hartmann, Gernot Marx, Ferdinand Binkofski, Carsten Finke, Jörg B. Schulz, Ana Sofia Costa, Kathrin Reetz |
| 23 |
[GO] |
2021―Nov―26 |
COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease |
Simone Beretta, Andrea Stabile, Claudia Balducci, Jacopo C. DiFrancesco, Adriana Patruno, Roberto Rona, Michela Bombino, Cristina Capraro, Francesca Andreetta, Paola Cavalcante, Fabio Moda, Giuseppe Citerio, Giuseppe Foti, Graziella Bogliun, Carlo Ferrarese |
| 24 |
[GO] |
2021―Nov―16 |
Before attributing encephalomyelitis to SARS-CoV-2 vaccinations thoroughly exclude differentials |
Josef Finsterer |
| 25 |
[GO] |
2021―Oct―12 |
Reply to: Before attributing encephalomyelitis to SARS-CoV-2 vaccinations exclude differentials |
Karolina Kania, Wojciech Ambrosius, Elzbieta Tokarz Kupczyk, Wojciech Kozubski |
| 26 |
[GO] |
2021―Sep―04 |
Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2 |
Karolina Kania, Wojciech Ambrosius, Elzbieta Tokarz Kupczyk, Wojciech Kozubski |
| 27 |
[GO] |
2021―Jul―11 |
Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound |
Ellen Farr, Alexis R. Wolfe, Swati Deshmukh, Leslie Rydberg, Rachna Soriano, James M. Walter, Andrea J. Boon, Lisa F. Wolfe, Colin K. Franz |
| 28 |
[GO] |
2021―Jul―08 |
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France |
Maria Pia Sormani, Marco Salvetti, Pierre Labauge, Irene Schiavetti, Helene Zephir, Luca Carmisciano, Caroline Bensa, Nicola De Rossi, Jean Pelletier, Cinzia Cordioli, Sandra Vukusic, Lucia Moiola, Philippe Kerschen, Marta Radaelli, Marie Théaudin, Paolo Immovilli, Olivier Casez, Marco Capobianco, Jonathan Ciron, Maria Trojano, Bruno Stankoff, Alain Créange, Gioacchino Tedeschi, Pierre Clavelou, Giancarlo Comi, Eric Thouvenot, Mario Alberto Battaglia, Thibault Moreau, Francesco Patti, Jérôme De Sèze, Celine Louapre |
| 29 |
[GO] |
2021―Mar―30 |
Multiple sclerosis, rituximab, and COVID-19 |
Annette Langer-Gould, Jessica B. Smith, Bonnie H. Li, Brandon E Beaber, Sonu M Brara, Julie Debacker, Allen Scott Nielsen, Samira Amirova, Oluwasheyi Ayeni |
| 30 |
[GO] |
2021―Mar―29 |
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy |
Umberto Pensato, Lorenzo Muccioli, Ilaria Cani, Damir Janigro, Pier Luigi Zinzani, Maria Guarino, Pietro Cortelli, Francesca Bisulli |
| 31 |
[GO] |
2021―Mar―23 |
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers” |
Edith L Graham, Jeffrey R Clark, Zachary S Orban, Patrick H Lim, April L Szymanski, Carolyn Taylor, Rebecca M DiBiase, Dan Tong Jia, Roumen Balabanov, Sam U Ho, Ayush Batra, Eric M Liotta, Igor J Koralnik |
| 32 |
[GO] |
2021―Feb―22 |
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases |
Seth N. Levin, Shruthi Venkatesh, Katie E. Nelson, Yi Li, Ines Aguerre, Wen Zhu, Karman Masown, Kathryn T. Rimmer, Claudiu I. Diaconu, Kaho B. Onomichi, Victoria M. Leavitt, Libby L. Levine, Rebecca Strauss-Farber, Wendy S. Vargas, Brenda Banwell, Amit Bar-Or, Joseph R. Berger, Andrew D. Goodman, Erin E. Longbrake, Jiwon Oh, Bianca Weinstock-Guttman, Kiran T. Thakur, Keith R. Edwards, Claire S. Riley, Zongqi Xia, Philip L. De Jager |
| 33 |
[GO] |
2021―Feb―22 |
A meta-analysis of the global impact of the COVID-19 pandemic on stroke care & the Houston Experience |
Sujan T. Reddy, Nikunj Satani, Jennifer E. S. Beauchamp, Sudhakar Selvaraj, Suja S. Rajan, Mohammad H. Rahbar, Amirali Tahanan, Sori Kim, Travis Holder, Xiaoqian Jiang, Luyao Chen, Haris Kamal, Hari Kishan R. Indupuru, Tzu-Ching Wu, Sean I. Savitz |
| 34 |
[GO] |
2021―Jan―29 |
Reply to COVID-19 encephalopathy, Bayes rule, and a plea for case-control studies |
Eric M. Liotta, Ayush Batra, Igor J. Koralnik |
| 35 |
[GO] |
2021―Jan―29 |
COVID-19 encephalopathy, Bayes rule, and a plea for case-control studies |
Esther Arbona-Haddad, Ivo W. Tremont-Lukats, Bhanu Gogia, Prashant K. Rai |
| 36 |
[GO] |
2020―Dec―30 |
Experiences of telemedicine in neurological out-patient clinics during the COVID-19 pandemic |
Espen Saxhaug Kristoffersen, Else Charlotte Sandset, Bendik Slagsvold Winsvold, Kashif Waqar Faiz, Anette Margrethe Storstein |
| 37 |
[GO] |
2020―Dec―20 |
ANA Webinars: Clinical and basic research resilience during COVID-19 |
Michelle C. Johansen, Michelle Jones-London, Walter Koroshetz, Eliezer Masliah, Avindra Nath, Vicky Whittemore, Justin C. McArthur |
| 38 |
[GO] |
2020―Nov―17 |
The case of a 69-year-old man with COVID-19 and encephalopathy |
Trevor E. Cline, Navdeep Sangha |
| 39 |
[GO] |
2020―Oct―05 |
Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients |
Eric M. Liotta, Ayush Batra, Jeffrey R. Clark, Nathan A. Shlobin, Steven C. Hoffman, Zachary S. Orban, Igor J. Koralnik |
| 40 |
[GO] |
2020―Aug―27 |
Neurological manifestations of coronavirus infections - a systematic review |
Jesper Almqvist, Tobias Granberg, Antonios Tzortzakakis, Stefanos Klironomos, Evangelia Kollia, Claes Öhberg, Roland Martin, Fredrik Piehl, Russell Ouellette, Benjamin V. Ineichen |
| 41 |
[GO] |
2020―May―20 |
Prolonged Confusional state as first manifestation of COVID-19 |
Isabel Butt, Vijay Sawlani, Tarekegn Geberhiwot |
| 42 |
[GO] |
2020―May―14 |
De Novo Status Epilepticus in patients with COVID-19 |
Sana Somani, Sandipan Pati, Tyler Gaston, Alissa Chitlangia, Shruti Agnihotri |
|
